Head-to-head weight loss
From the only large trial that directly compared these two drugs. 751 adults with obesity, 72 weeks at maximum dose.
Tirzepatide showed higher average weight loss in this direct comparison. Individual results vary substantially.
That is the headline number. But neither drug is universally "better" — they differ on cardiovascular evidence, cost, and form. Here is the fuller picture.
Weight loss at maximum approved dose
Including the oral semaglutide pill, which was not part of the head-to-head trial.
For a 240 lb person. Averages from clinical trials.
Monthly cost
The oral pill option is dramatically cheaper than either injection.
List prices and manufacturer self-pay programs. Insurance coverage varies.
Beyond weight loss
Heart protection
Form & convenience
Side effects
Usually peaks weeks 2–4, fades by week 8–12
Two oral GLP-1 pills are now FDA-approved: Oral Wegovy (~16.6% weight loss, $149/month) and Foundayo (~12.4% weight loss, no food restrictions).
See the Oral Wegovy vs Foundayo comparison →Common questions
Not sure where to start? Our 2-minute quiz can help.
Take the quiz →Next step most people take
Backed by evidence · Every claim linked to its source
Last reviewed: April 2026